Synergism of FAK and ROS1 inhibitors in the treatment of <i>CDH1</i>-deficient cancers mediated by FAK-YAP signaling
Jiaming Gao(Ruijin Hospital), Ruibao Ren(Ruijin Hospital)
Cited by 13
Related Papers
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia
|Proceedings of the National Academy of Sciences|2017|148
The Aging Biomarker Consortium represents a new era for aging research in China
|Nature Medicine|2023|59
Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4A
|Journal of Hematology & Oncology|2015|28
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
|Journal of Experimental & Clinical Cancer Research|2024|19